Medical Oncology II

Course dates

Offered next time fall 2026.

The course is available every second year.

Examination

Please find dates and details about the exam in the exam schedule.

Having completed the course, the student must be able to:
 
Knowledge

• Describe and reflect about common ethical, safety, and environmental considerations in treatment with cytostatic drugs in companion animal cancer patients.
• Define, identify and demonstrate overview of commonly used companion animal cancer chemotherapy protocols and multimodality approaches to therapeutic management.
• List, classify, and demonstrate critical reflection on existing and new medical or combined approaches to oncology patient therapy and client education.
• Demonstrate appropriate understanding regarding nutrition, nutraceuticals and supplementary therapies in veterinary cancer patients.
• Be current on specific blood product transfusion-guidelines and demonstrate an understanding of hemostatic disorders in veterinary cancer patients.
• Have an in depth knowledge of cancer related pain.
• Understand the use of radiotherapy in veterinary cancer patients for their own practice.

 
Skills

• Use appropriate procedures and administration protocols for medical management and follow up of specific companion animal cancer types.
• Interpret, assess and reflect on stage and grade of cancer in relation to planning of the therapeutic approach incl. which modalities, protocol and the administration of chemotherapy in individual patients.
• Plan, apply and integrate new evidence based scientific approaches to plan and administer medical therapy in companion animal cancer patients, pain management, nutritional management and other supportive therapy.
• Detect, assess and address adverse effects to cancer chemotherapy effectively and in a timely fashion.
• Communicate effectively in writing and pass on therapeutic results to relevant parties.

 
Competences

• Evaluate and manage the medical therapy of companion animal cancer patients which may necessitate novel solutions and approaches identified from current medical literature or other ressources as they pertain to the individual patient.
• Work independently, take responsibility for, predict, and prognosticate based on response to therapy for commonly medically treated companion animal cancers.
• Collaborate constructively within and between specialists/​professionals and lay persons involved in companion animal medical cancer treatment.
• Independently evaluate and structure own learning processes and continuously obtain new knowledge within the medical management of companion animal cancer patients.

You must meet the following criteria to be admitted to this course: 

EU/EEA citizens*
Single course student: 33,500 DKK
Master student: 30,000 DKK 

Non-EU/EEA citizens
Single course student: 37,740 DKK
Master student: 34,240 DKK

Tuition fees include course materials and lunch/coffee. Books are not included in the tuition fees and must be purchased by the participants.

Terms and conditions.

*Citizens of the EU, EEA or Switzerland is entitled to a subsidised tuition fee, due to EU legislation, hence the difference in price.